Nada L. Babovic

Belgrade, SE, Serbia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Increased circulating monocyte MDSCs positively correlate with serum Interleukin-10 in metastatic melanoma patients.

Increased circulating monocyte MDSCs positively correlate with serum Interleukin-10 in metastatic melanoma patients.

Journal: Innate immunity

Published: May 10, 2023

Circulating IL-6 is associated with disease progression in BRAFwt metastatic melanoma patients receiving anti-PD-1 therapy.

Circulating IL-6 is associated with disease progression in BRAFwt metastatic melanoma patients receiving anti-PD-1 therapy.

Journal: Journal of clinical pathology

Published: October 07, 2022

Increased circulating TGF-β1 is associated with impairment in NK cell effector functions in metastatic melanoma patients.

Increased circulating TGF-β1 is associated with impairment in NK cell effector functions in metastatic melanoma patients.

Journal: Growth factors (Chur, Switzerland)

Published: September 21, 2022

Real World Overall Survival of Patients With Metastatic Renal Cell Carcinoma Treated With Only Available Sunitinib and Pazopanib in First-Line Setting.

Real World Overall Survival of Patients With Metastatic Renal Cell Carcinoma Treated With Only Available Sunitinib and Pazopanib in First-Line Setting.

Journal: Frontiers in oncology

Published: March 08, 2022

Interleukin-4-induced natural killer cell antitumor activity in metastatic melanoma patients.

Interleukin-4-induced natural killer cell antitumor activity in metastatic melanoma patients.

Journal: European cytokine network

Published: December 03, 2020

AROME-ESO Oncology Consensus Conference: access to cancer care innovations in countries with limited resources. Association of Radiotherapy and Oncology of the Mediterranean Area (AROME-Paris) and European School of Oncology (ESO - Milan).

AROME-ESO Oncology Consensus Conference: access to cancer care innovations in countries with limited resources. Association of Radiotherapy and Oncology of the Mediterranean Area (AROME-Paris) and European School of Oncology (ESO - Milan).

Journal: Journal of B.U.ON. : official journal of the Balkan Union of Oncology

Published: December 02, 2019

Access to innovative medicines for metastatic melanoma worldwide: Melanoma World Society and European Association of Dermato-oncology survey in 34 countries.

Access to innovative medicines for metastatic melanoma worldwide: Melanoma World Society and European Association of Dermato-oncology survey in 34 countries.

Journal: European journal of cancer (Oxford, England : 1990)

Published: September 08, 2018

Evaluation of the Functional Capacity of NK Cells of Melanoma Patients in an In Vitro Model of NK Cell Contact with K562 and FemX Tumor Cell Lines.

Evaluation of the Functional Capacity of NK Cells of Melanoma Patients in an In Vitro Model of NK Cell Contact with K562 and FemX Tumor Cell Lines.

Journal: The Journal of membrane biology

Published: February 02, 2017

More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatments.

More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatments.

Journal: European journal of cancer (Oxford, England : 1990)

Published: January 19, 2017

Beneficial in-vitro effects of interleukin-2, interleukin-12, and their combination on functional and receptor characteristics of natural killer cells in metastatic melanoma patients with normal serum lactate dehydrogenase levels.

Beneficial in-vitro effects of interleukin-2, interleukin-12, and their combination on functional and receptor characteristics of natural killer cells in metastatic melanoma patients with normal serum lactate dehydrogenase levels.

Journal: Melanoma research

Published: September 14, 2016

Clinicopathological characteristics, diagnosis and treatment of melanoma in Serbia--the Melanoma Focus Study.

Clinicopathological characteristics, diagnosis and treatment of melanoma in Serbia--the Melanoma Focus Study.

Journal: Vojnosanitetski pregled

Published: June 05, 2015

Decreased expression of pSTAT, IRF-1 and DAP10 signalling molecules in peripheral blood lymphocytes of patients with metastatic melanoma.

Decreased expression of pSTAT, IRF-1 and DAP10 signalling molecules in peripheral blood lymphocytes of patients with metastatic melanoma.

Journal: Journal of clinical pathology

Published: May 04, 2015

Showing 1-12 of 16

Last Updated: 09/26/2026